EUVIMEDEUVIMED entdecken
Crossref

Improvement in cystic fibrosis newborn screening program outcomes with genetic counseling via telemedicine

Heather J Stalker, Amy R Jonasson, Sidney M Hopfer, Melanie Sue Collins iD

Pediatric Pulmonology · 2023

DOI: 10.1002/ppul.26678 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Pulmonology, 2023. Verfasst von Heather J Stalker und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hayward Telegenetics Center, Division of Pediatric Genetics and Metabolism, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Genetic Counseling, Cystic Fibrosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Cystic Fibrosis Foundation, Hayward.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The Cystic Fibrosis Foundation (CF Foundation) recommends the provision of genetic counseling (GC) to help educate families and decrease anxiety around the cystic fibrosis (CF) newborn screening process. Unfortunately, access to genetic counselors is limited, especially for CF trained genetic counselors. We hypothesized that the GC process for families could be improved by utilizing telemedicine to leverage the availability of two dedicated, CF trained genetic counselors to provide access to GC for several CF centers. In addition, we hoped to demonstrate that use of trained CF genetic counselors, delivering GC via telemedicine at the time of sweat testing, would provide families with understanding of CF genetics as well as result in high satisfaction with the newborn screening process.

Methods

GC was provided by CF trained genetic counselors via telemedicine at the time of sweat testing. Following the counseling session, families were administered an anonymous written survey to evaluate their impression of the services provided. A subset of 50 families was recruited for an assessment of gained knowledge regarding CF genetics using the Ciske knowledge inventory. Using χ 2 analysis, Ciske knowledge inventory data from our telemedicine GC families was compared to counseled and uncounseled Ciske historical controls. Lastly, in‐depth interviews about the newborn screening process for CF were performed with 10 families and interviews were coded for emerging themes.

Results

During the 4 years of the study, 250 patients received GC. Overall comfort with the counseling rated 4.77 out of 5 using a Likert scale. After counseling by telemedicine, parents demonstrated improved understanding of the genetic implications of an abnormal CF newborn screen for their family, with 100% of families understanding that their child was a carrier for CF as compared to 97.2% of counseled ( p = .023) and 78.5% of uncounseled ( p = .0007) from Ciske historical controls. The study group also showed improvement in understanding of both parents possibly being carriers, with an 87.7% correct response rate compared to a 37.0% correct response rate in the counseled group ( p < .0001) and a 35.4% correct response rate in the non‐counseled group ( p < .0001) from Ciske historical controls. Subgroup analysis at one site showed a significant increase in the number of infants with completed sweat tests from previous years (49% in 2013 vs. 80% in 2017 during the study, p < .0001).

Conclusions

GC by telemedicine was well received by families and demonstrated improved family knowledge acquisition and understanding of CF as it related to risks for their child as well as identification of risks for other family members. Furthermore, in addition to an increase is those receiving GC, a subgroup analysis demonstrated a significant increase in the number of infants receiving sweat tests. This study demonstrates that GC via telemedicine for CF is feasible and demonstrates improvement in parent understanding of CF genetics. Furthermore, this method can be implemented effectively across a wide geographical area with a limited number of CF trained genetic counselors to improve access to care for patients and families.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic CounselingCystic FibrosisInfantInfant, NewbornChildHumansNeonatal ScreeningGenetic Carrier ScreeningCystic Fibrosis Transmembrane Conductance RegulatorGenetic Testing

Stichwörter der Autor:innen

cystic fibrosisgenetic counselingnewborn screeningtelemedicine

Substanzen

Cystic Fibrosis Transmembrane Conductance Regulator

Autor:innen und Institutionen

  • Hayward Telegenetics Center, Division of Pediatric Genetics and Metabolism, University of Florida, Gainesville, Florida, USA.
  • Pathology and Laboratory Medicine, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
  • Central Connecticut Cystic Fibrosis Center/Connecticut Childrens' Medical Center, Division of Pediatric Pulmonary and Sleep Medicine, University of Connecticut School of Medicine, Farmington, Connecticut, USA.

ORCID-Profile: Melanie Sue Collins

Förderung

  • Cystic Fibrosis Foundation
  • Hayward

Zitieren

APA

Stalker, H. J., Jonasson, A. R., Hopfer, S. M., & Collins, M. S. (2023). Improvement in cystic fibrosis newborn screening program outcomes with genetic counseling via telemedicine. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26678

Vancouver

Stalker HJ, Jonasson AR, Hopfer SM, Collins MS. Improvement in cystic fibrosis newborn screening program outcomes with genetic counseling via telemedicine. Pediatric Pulmonology. 2023. doi:10.1002/ppul.26678

BibTeX
@article{Stalker2023,
  author = {Stalker, Heather J and Jonasson, Amy R and Hopfer, Sidney M and Collins, Melanie Sue},
  title = {Improvement in cystic fibrosis newborn screening program outcomes with genetic counseling via telemedicine},
  journal = {Pediatric Pulmonology},
  year = {2023},
  doi = {10.1002/ppul.26678}
}
Kostenlos starten →